A 5-HT Antagonist (UP 26-91) versus Codeine and Placebo in a Human Experimental Pain Study
BACKGROUND: This double-blind, randomized, crossover study compared the potential analgesic effect of the serotonin receptor antagonist UP 26-91 (50 mg, 150 mg and 300 mg) with that of codeine (100 mg) and placebo by use of different human experimental pain models.
Saved in:
Main Authors: | Lars Arendt-Nielsen, Poul Pedersen, Lars Poulsen, Ole Kæseler Andersen, Peter Bjerring, Isabelle Coste, Jorge Insuasty, Søren Sindrup, Asbjørn Mohr Drewes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2000/842198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pain System in Oesophageal Disorders: Mechanisms, Clinical Characteristics, and Treatment
by: Christian Lottrup, et al.
Published: (2011-01-01) -
Practice implications and recommendations for managing codeine misuse and dependence
by: Bergin Michael, et al.
Published: (2015-12-01) -
Determination of Morphine and Codeine in Human Urine by Gas Chromatography-Mass Spectrometry
by: Xiaoqian Zhang, et al.
Published: (2013-01-01) -
Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT2A Antagonist
by: Mahantesh Namdev Jadhav, et al.
Published: (2013-01-01) -
Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trialResearch in context
by: Katrine Lundby Høyer, et al.
Published: (2025-01-01)